Nasdaq Crvs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq crvs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Crvs Today - Breaking & Trending Today

Towerview LLC Acquires 94,395 Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)

Towerview LLC boosted its holdings in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) by 27.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 436,873 shares of the company’s stock after purchasing an additional 94,395 shares during the period. Corvus Pharmaceuticals accounts for approximately 0.5% of Towerview LLC’s portfolio, making the stock its 17th […] ....

Cantor Fitzgerald , Vanguard Group Inc , Renaissance Technologies , Quarter For Corvus Pharmaceuticals , Corvus Pharmaceuticals Inc , Corvus Pharmaceuticals Stock Performance , Blackrock Inc , Corvus Pharmaceuticals Profile , News Ratings For Corvus Pharmaceuticals Daily , Corvus Pharmaceuticals , Free Report , Sigma Advisers , Two Sigma Investments , Sigma Investments , Get Free Report , Visit Holdingschannel , Corvus Pharmaceuticals Daily , Nasdaq Crvs , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Short Interest Update

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 1,490,000 shares, an increase of 17.3% from the February 29th total of 1,270,000 shares. Based on an average daily trading volume, of 218,100 […] ....

Corvus Pharmaceuticals Stock Performance , Tucker Asset Management , Corvus Pharmaceuticals Inc , Cantor Fitzgerald , Renaissance Technologies , News Ratings For Corvus Pharmaceuticals Daily , Corvus Pharmaceuticals Company Profile , Corvus Pharmaceuticals , Institutional Trading Of Corvus Pharmaceuticals , Tower Research Capital , Charles Schwab Investment Management Inc , Get Free Report , Research Capital , Street Corp , Asset Management , Charles Schwab Investment Management , Corvus Pharmaceuticals Daily , Nasdaq Crvs ,

Corvus Pharmaceuticals (CRVS) Set to Announce Earnings on Tuesday

Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report) is set to release its earnings data after the market closes on Tuesday, November 7th. Analysts expect Corvus Pharmaceuticals to post earnings of ($0.16) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. Corvus Pharmaceuticals […] ....

Hedge Funds Weigh In On Corvus Pharmaceuticals , Renaissance Technologies , Corvus Pharmaceuticals Inc , Corvus Pharmaceuticals Price Performance , Earnings History For Corvus Pharmaceuticals , Vanguard Group Inc , Cantor Fitzgerald , Corvus Pharmaceuticals Company Profile , Corvus Pharmaceuticals , News Ratings For Corvus Pharmaceuticals Daily , Blackrock Inc , Get Free Report , Sigma Advisers , Two Sigma Investments , Sigma Investments , Corvus Pharmaceuticals Daily , Nasdaq Crvs ,